PattersonUTI Energy (PTEN)
(Delayed Data from NSDQ)
$10.68 USD
+0.09 (0.85%)
Updated May 3, 2024 04:00 PM ET
After-Market: $10.69 +0.01 (0.09%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$10.68 USD
+0.09 (0.85%)
Updated May 3, 2024 04:00 PM ET
After-Market: $10.69 +0.01 (0.09%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth F Momentum A VGM
Zacks News
Why Is Patterson-UTI (PTEN) Down 7% Since Last Earnings Report?
by Zacks Equity Research
Patterson-UTI (PTEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Patterson UTI (PTEN) Q1 Earnings & Sales Beat Estimates
by Zacks Equity Research
Patterson-UTI (PTEN) expects capex of $510 million, Contract Drilling capex of $290 million and Pressure Pumping capex of $150 million for 2023.
Nabors Industries (NBR) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Nabors (NBR) delivered earnings and revenue surprises of -151.89% and 2.74%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Patterson-UTI (PTEN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Patterson-UTI (PTEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Options Traders Betting on a Big Move in Patterson-UTI (PTEN) Stock?
by Zacks Equity Research
Investors need to pay close attention to Patterson-UTI (PTEN) stock based on the movements in the options market lately.
Patterson-UTI (PTEN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Patterson-UTI (PTEN) closed at $11.70 in the latest trading session, marking a +1.65% move from the prior day.
Should Vanguard S&P Small-Cap 600 Value ETF (VIOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VIOV
Patterson-UTI (PTEN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Patterson-UTI (PTEN) closed at $10.83, marking a +1.21% move from the previous day.
Wall Street Analysts See Patterson-UTI (PTEN) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Patterson-UTI (PTEN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Patterson-UTI (PTEN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Patterson-UTI (PTEN) closed at $11.71, marking a +0.43% move from the previous day.
Patterson-UTI (PTEN) Stock Moves -1.2%: What You Should Know
by Zacks Equity Research
Patterson-UTI (PTEN) closed at $13.15 in the latest trading session, marking a -1.2% move from the prior day.
Patterson-UTI (PTEN) Down 7.5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Patterson-UTI (PTEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should You Invest in Patterson-UTI (PTEN) Based on Bullish Wall Street Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Patterson-UTI (PTEN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Patterson-UTI (PTEN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Patterson-UTI (PTEN) closed at $14.98 in the latest trading session, marking a +0.6% move from the prior day.
Patterson-UTI's (PTEN) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Patterson-UTI Energy's (PTEN) Q4 sales and earnings beat estimates with strong performance across various segments. It also projects a rig count increase and $550 million capex for 2023.
Should Value Investors Buy Nabors Industries (NBR) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Patterson-UTI (PTEN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Patterson-UTI (PTEN) delivered earnings and revenue surprises of 6.98% and 3.81%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NuStar Energy (NS) Beats on Q4 Earnings and Revenues
by Zacks Equity Research
NuStar Energy (NS) expects to generate net income in the range of $202-$240 million and EBITDA in the range of $700-$760 million in 2023.
Northern (NOG) Updates Q4 Production Numbers, Hikes Dividend
by Zacks Equity Research
Northern Oil and Gas (NOG) reports a Q4 production decline due to severe weather but expects higher average daily oil production in its full-year 2022 guidance.
5 Best High Earnings Yield Picks to Grow Your Wealth
by Rimmi Singhi
Stocks with high earnings yield have the potential to provide greater returns. PTEN, JBL, CPRX, AGCO and URBN are some stocks boasting high earnings yield to power your portfolio.
Core Laboratories (CLB) Q4 Earnings Beat, Revenues Miss
by Zacks Equity Research
Core Labs' (CLB) revenues for the first quarter of 2023 are anticipated in the $125-$129 million range, while the operating income is estimated in the $11.5-$14.5 million band.
Transocean (RIG) Wins 910-Day Drilling Deal Set to Start in Q3
by Zacks Equity Research
Transocean (RIG) lands 910-day contract for Dhirubhai Deepwater KG2 in Brazil.
TC Energy's (TRP) Coastal GasLink Cost to Balloon Further
by Zacks Equity Research
TC Energy???s Coastal GasLink project cost has risen to C$14.5 billion, causing the company to revise its 2023 capital spending forecast to C$11.5- C$12 billion, up from C$9.5 billion previously.
TechnipFMC (FTI) Wins Upto $1B iEPCI Contract From Aker BP
by Zacks Equity Research
TechnipFMC's (FTI) iEPCI contract from Aker BP involves the engineering, procurement, construction, and installation of subsea production systems, controls, pipelines and umbilicals.
Patterson-UTI's (PTEN) Q4 Earnings: Another Beat in the Cards?
by Zacks Equity Research
Higher revenues from the Contract Drilling and Pressure Pumping segments are likely to have boosted Patterson-UTI Energy's (PTEN) fourth-quarter results.